OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Editorial Board	184
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	143
Inhaled aerosol viral-vectored vaccines against tuberculosis	116
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	88
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	87
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	74
Transmission patterns of hepatitis E virus	69
The enigmatic roles of Anelloviridae and Redondoviridae in humans	67
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	65
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	64
Editorial Board	63
Editorial overview: Viral pathogenesis	55
Virus–host protein interactions as footprints of human cytomegalovirus replication	49
Structural basis for neutralization of enterovirus	49
Human placental models for studying viral infections	49
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	46
Editorial overview: Mechanisms in the molecular interactions of plants with viruses and viroids	45
Editorial Board	44
The journey of herpesvirus capsids and genomes to the host cell nucleus	42
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	39
Recent progress in development of monoclonal antibodies against human cytomegalovirus	39
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1	39
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	39
Emerging technologies in the study of the virome	36
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	35

New preventive strategies for respiratory syncytial virus infection in children	34
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	34
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	33
A complex immune communication between eicosanoids and pulmonary macrophages	32
Epigenetic control of the Epstein-Barr lifecycle	31
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	31
Engineering therapeutic phages for enhanced antibacterial efficacy	30
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	30
Mitigation of evolved bacterial resistance to phage therapy	28
Platelets in the pathogenesis of flavivirus disease	28
Editorial Board	27
Perspective on taxonomic classification of uncultivated viruses	27
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	26
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	26
Asymmetry in icosahedral viruses	26
When good turns bad: how viruses exploit innate immunity factors	26
Retasking of canonical antiviral factors into proviral effectors	26
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	25
Tissue-resident memory T cells in protective immunity to influenza virus	25
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	25
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	24
Modeling zoonotic and vector-borne viruses	24
Mechanisms of HCV resistance to broadly neutralizing antibodies	24
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	23
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	23
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	23
Oncogenic Animal Herpesviruses	23
Immune responses to human respiratory coronaviruses infection in mouse models	22
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	22
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	22
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	22
The virome of vector mosquitoes	21
Deimmunization of flagellin adjuvant for clinical application	21
Advances in human monoclonal antibody therapy for HBV infection	20
Broadly neutralizing antibodies against COVID-19	20
The impact of high-resolution structural data on stemming the COVID-19 pandemic	20
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	20
Antigenic evolution of SARS coronavirus 2	20
Bat virome research: the past, the present and the future	20
Editorial overview	20
Viral Z-RNA triggers ZBP1-dependent cell death	19
Editorial Board	19
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	19
Editorial Board	19
Structure and physiology of giant DNA viruses	17
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2	17
Early signaling pathways in virus-infected cells	16
Editorial overview: Special issue on phage therapy	16
Mapping conformational epitopes by NMR spectroscopy	16
Microbiota as a potentially-modifiable factor influencing COVID-19	16

Editorial overview: Viral immunology before COVID-19	16
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers	15
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	15
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	15
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	15
Structural insights into hepatitis C virus neutralization	15
How and why RNA genomes are (partially) ordered in viral capsids	15
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	15
Accumulation of host cell genetic errors following high-risk HPV infection	15
The influence of microbiota-derived metabolites on viral infections	15
Editorial overview: Engineering elimination of chronic viral hepatitis	14
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
Editorial overview: Special issue on virus structure and expression in current opinion in virology	14
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success	14
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	14
Editorial overview: Virus structure and expression	14
Proteases and variants: context matters for SARS-CoV-2 entry assays	13
The intestinal virome: lessons from animal models	13
Editorial Board	13
Natural killer cells and unconventional T cells in COVID-19	13
Koala retrovirus and neoplasia: correlation and underlying mechanisms	13
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	13
Editorial Board	13
Phage therapy for secondary bacterial infections with COVID-19	13
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	12
European regulatory aspects of phage therapy: magistral phage preparations	12
Cryo-EM to visualize the structural organization of viruses	12
Broad neutralizing antibody-based strategies to tackle influenza	12
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	12
Editorial Board	12
Lying low-chromatin insulation in persistent DNA virus infection	12
Virus structure and structure-based antivirals	12
Animal models of SARS-CoV-2 transmission	11
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	11
The role of human lipoproteins for hepatitis C virus persistence	11
Endocytosis of Bacteriophages	11
The long and winding road: human papillomavirus entry and subcellular trafficking	11
Therapeutic approaches to Epstein–Barr virus cancers	11
Zoonotic disease and virome diversity in bats	11
A comparative review of adenovirus A12 and C5 oncogenes	11
Editorial Board	11
Ex vivo culture models to study viral infections of the liver	10
Understanding T cell aging to improve anti-viral immunity	10
Editorial Board	10
Editorial Board	10
Know your enemy and know yourself – the case of SARS-CoV-2 host factors	10
Co-opted membranes, lipids, and host proteins: what have we learned from tombusviruses?	10
An overview of the current state of phage therapy for the treatment of biofilm-related infections	10
Viral determinants influencing intra- and intercellular communication in cytomegalovirus infection	10
Proteomic analysis of antiviral innate immunity	10
Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection	10
Editorial overview: 2022 “Virus–Host Interaction” section of Current Opinion in Virology	10
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	10